.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
India has achieved a landmark milestone in managing rare genetic conditions through the establishment of a specialized repository. The newly inaugurated Lysosomal Storage Disorders Biobank in Gujarat offers significant hope for patients seeking affordable diagnostic pathways. Consequently, this facility at the FRIGE's Institute of Human Genetics consolidates two decades of rigorous clinical research. Furthermore, the repository currently manages biological samples from more than 530 patients across the country.
The facility serves as a critical infrastructure for identifying complex genetic mutations in a resource-limited setting. By integrating DNA data with detailed clinical profiles, researchers can now accelerate the development of indigenous medical solutions. Moreover, the biobank includes serum, plasma, and genomic DNA samples to support long-term healthcare outcomes. Although treatment costs for these conditions often exceed Rs 1 crore annually, this initiative aims to lower economic barriers. Therefore, clinicians can expect improved access to cost-effective diagnostic kits in the near future.
The institute recently developed a molecular probe-based sequencing asset to streamline the identification of rare metabolic conditions. This technological advancement allows for the comprehensive diagnosis of 19 different lysosomal storage disorders simultaneously. Additionally, the Gujarat State Biotechnology Mission provided essential funding to foster this genetic innovation. Because the biobank functions as a national resource, it strengthens India's self-reliance in advanced medical research. Ultimately, these efforts position Gujarat as a primary hub for global genetic advancements.
Q1: What types of biological samples does the new biobank store?
The biobank maintains a comprehensive repository including serum, plasma, whole blood genomic DNA samples, and urine precipitates from over 530 patients.
Q2: How does the biobank impact the cost of diagnosing rare disorders?
By utilizing indigenous molecular probe-based sequencing assets, the facility significantly reduces the cost of diagnosing multiple disorders compared to traditional methods.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Gujarat launches India's first national biobank for Lysosomal Storage Disorders to provide affordable diagnosis and genetic research for rare diseases....
5 months ago
A new study reveals that lipid-related metabolic dysregulation, marked by elevated TG/HDL-C ratio and glymphatic changes, independently impacts survival in idiopathic normal pressure hydrocephalus.
Today
Explore real-world data showing how private oncogenetics and molecular tumor boards achieve 3-week consult turnaround, high ctDNA actionability, and vital germline variant detection, enhancing individualized cancer care and familial risk assessment.
Today
A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
